BioMarin Pharmaceutical Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2009
Total Assets: $917.2M
Liabilities Breakdown FY2009
Total Liabilities: $595.0M
Asset Breakdown
Total Assets: $917.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $167.2M | 18.2% |
| Accounts Receivable | $73.5M | 8.0% |
| Inventory | $78.7M | 8.6% |
| Property, Plant & Equipment | $199.1M | 21.7% |
| Goodwill | $23.7M | 2.6% |
| Intangible Assets | $41.0M | 4.5% |
| Other Assets | $334.0M | 36.4% |
Liabilities Breakdown
Total Liabilities: $595.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $595.0M | 100.0% |